MIAMI LAKES, Fla., Nov. 5, 2014 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) will report its third quarter 2014 financial results Monday, November 10, 2014 at approximately 7:30 a.m. Eastern Time. ERBA Chief Executive Officer Mohan Gopalkrishnan, will host a management conference call at 9:00 a.m. Eastern Time to discuss the financial results and business developments.
Conference Access Details:
| Time: | 9:00 a.m. Eastern Time, November 10, 2014 |
| Live Webcast: | www.erbadiagnostics.com (Investor Relations section) |
| Live Dial-In: | 1-877-300-8521 (U.S.) |
| 1-412-317-6026 (International) |
A replay of the call will be available via webcast and will be accessible from the Investor Relations section of the Company's website under 'Webcasts & Presentations.'
About ERBA Diagnostics, Inc.
ERBA Diagnostics, Inc. (www.erbadiagnostics.com), headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distributes in the United States and internationally, proprietary diagnostic reagents, test kits and instrumentation, primarily for autoimmune and infectious diseases, clinical chemistry, hematology and diabetes through its six subsidiaries -- Diamedix Corporation (U.S.), Delta Biologicals S.r.l. (Europe), ImmunoVision, Inc. (U.S.), Drew Scientific, Inc. (U.S.), JAS Diagnostics, Inc. (U.S.), and Erba Diagnostics Mexico S.A. (Latin America).